Skip to main content
Equibles

D. E. Shaw & Co., Inc.

Position in ZYME — Zymeworks Inc.

CIK 1009207 New York, NY
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,785,254
-$2,114,695 QoQ
Shares Held
144,807
-38.5% QoQ
Ownership
0.204%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 202 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 217 Biotechnology names. ZYME ranks #107 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 5,877,959 $626,707,987
2 ALNY
Alnylam Pharmaceuticals, Inc.
 1,104,109 $332,369,932
3 EXEL
Exelixis, Inc.
 5,551,747 $302,070,554
4 BBIO
BridgeBio Pharma, Inc.
 3,633,007 $270,586,360
5 TGTX
Tg Therapeutics, Inc.
 3,400,808 $186,840,390
6 HALO
Halozyme Therapeutics, Inc.
 2,006,479 $157,047,110
7 AXSM
Axsome Therapeutics, Inc.
 604,753 $148,025,391
8 PTCT
Ptc Therapeutics, Inc.
 1,548,919 $126,345,322

All Filings in ZYME

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,785,254 144,807
2026-03-31 $5,899,949 235,621
2025-12-31 $5,892,285 223,786
2025-09-30 $2,167,844 126,923
2025-06-30 $3,203,902 255,291
2025-03-31 $751,509 63,099
2024-12-31 $305,097 20,840
2024-09-30 $273,364 21,782
2024-06-30 $372,363 43,756
2024-03-31 $285,228 27,113
2023-09-30 $412,531 65,068
2023-06-30 $426,418 49,354
2022-12-31 $2,901,809 369,187